Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018）
Clinical trial NCT05113459 · UNKNOWN
Trial details
- NCT number
- NCT05113459
- Sponsor
- Guoxin Li
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-18
- Primary completion
- 2023-12-18
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.